Research Articles

Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure

Authors: Seicean S, Seicean A, Alan N, Plana JC, Budd GT, Marwick TH
Publication: Circ Heart Fail, PubMed (PMID: 23425978)
Date: February 20, 2013
URL: http://circheartfailure.ahajournals.org/content/6/3/420.long

Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal stu

Authors: Brown TR, Vijarnsorn C, Potts J, Milner R, Sandor GG, Fryer C
Publication: Pediatr Blood Cancer, PubMed (PMID: 23382019)
Date: February 4, 2013
URL: http://onlinelibrary.wiley.com/doi/10.1002/pbc.24404/full

A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors

Authors: Heath EI, Infante J, Lewis LD, Luu T, Stephenson J, Tan AR, Kasubhai S, LoRusso P, Ma B, Suttle AB, Kleha JF, Ball HA, Dar MM
Publication: Cancer Chemother Pharmacol, PubMed (PMID: 23344712)
Date: January 24, 2013
URL: http://link.springer.com/article/10.1007%2Fs00280-012-2030-8

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors

Authors: Farolfi A, Melegari E, Aquilina M, Scarpi E, Ibrahim T, Maltoni R, Sarti S, Cecconetto L, Pietri E, Ferrario C, Fedeli A, Faedi M, Nanni O, Frassineti GL, Amadori D, Rocca A
Publication: Heart, PubMed (PMID: 23349345)
Date: January 24, 2013
URL: http://heart.bmj.com/content/99/9/634.long

Cancer genetics and the cardiotoxicity of the therapeutics

Authors: Lal H, Kolaja KL, Force T
Publication: J Am Coll Cardiol, PubMed (PMID: 23328609)
Date: January 22, 2013
URL: http://www.sciencedirect.com/science/article/pii/S0735109712044890

The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics

Authors: Scott JM, Lakoski S, Mackey JR, Douglas PS, Haykowsky MJ, Jones LW
Publication: Oncologist, PubMed (PMID: 23335619)
Date: January 18, 2013
URL: http://theoncologist.alphamedpress.org/content/18/2/221.long

Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.

Authors: Horacek JM, Jebavy L, Vasatova M, Pudil R, Tichy M, Jakl M, Maly J.
Publication: Bratislava Medical Journal
Date: 2013
URL: http://www.ncbi.nlm.nih.gov/pubmed/24329509

Early detection of anthracycline-induced cardiotoxicity using two-dimensional speckle tracking echocardiography.

Authors: Kang Y, Cheng L, Li L, Chen H, Sun M, Wei Z, Pan C, Shu X.
Publication: Cardiology Journal
Date: 2013
URL: http://czasopisma.viamedica.pl/cj/article/view/36492